TTP607 in Refractory Solid Malignancies

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2010

Conditions
Advanced CancersLymphoma
Interventions
DRUG

TTP607

3.3 mg/m\^2 given by central venous catheter over 1-4 hours, each day for 5 days in a row, for a 15 day cycle.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

vTv Therapeutics

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER